PROK
USDProKidney Corp. Class A Ordinary Shares
$2.800-0.010 (-0.356%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.810
High
$2.825
Low
$2.708
Volume
1.18M
Company Fundamentals
Market Cap
826.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.15M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.46Current $2.800High $7.13
Related News
GlobeNewswire
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
WINSTON-SALEM, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease
View more
Related Stocks
FIX
Comfort Systems USA Inc.
NASDAQ
Engineering & C...
FFIE
Faraday Future Intelligent Electric Inc.
NASDAQ
Auto Manufactur...
KRT
Karat Packaging Inc.
NASDAQ
Plastic Product...
ALSAU
Alpha Star Acquisition Corporation Units
NASDAQ
Blank Checks
GPCR
Structure Therapeutics Inc. American Depositary Shares
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.